Get the Stockscreener App
Bronte Capital Management Pty's Portfolio and 13F Filing
| Value: | $578M |
| CIK: | 0001471085 |
| Phone: | 0417337961 |
| Address: | Suite 1703, 101 Grafton St, Bondi Junction, C3 (2022) |
| Latest 13F Filing: | 2026-08-05 |
| # | Stock Name | Symbol | Current Price | Previous Holdings (# Shares) |
Current Holdings (# Shares) |
Current Value | Percent |
|---|---|---|---|---|---|---|---|
| 41 | Seer, Inc. Class A Common Stock | SEER | $2.08 | N/A | 15,109 | $31,427 | 0.01% |
| 42 | C4 Therapeutics, Inc. | CCCC | $2.61 | N/A | 10,349 | $27,011 | 0.00% |
| 43 | Alector, Inc. Common Stock | ALEC | $1.88 | N/A | 11,758 | $22,105 | 0.00% |
| 44 | Acumen Pharmaceuticals, Inc. Common Stock | ABOS | $1.75 | N/A | 10,716 | $18,699 | 0.00% |
| 45 | Blend Labs, Inc. | BLND | $0.92 | N/A | 19,247 | $17,626 | 0.00% |
| 46 | ALX Oncology Holdings Inc. Common Stock | ALXO | $0.89 | N/A | 18,095 | $16,190 | 0.00% |
| 47 | Coherus Oncology, Inc. Common Stock | CHRS | $1.05 | N/A | 15,262 | $16,025 | 0.00% |
| 48 | NovaBridge Biosciences American Depositary Shares | NBP | $1.28 | N/A | 11,192 | $14,326 | 0.00% |
| 49 | Milestone Pharmaceuticals Inc. Common Shares | MIST | $0.79 | N/A | 14,390 | $11,338 | 0.00% |
Related 13F Filings:
berkshire hathaway 13f,
sec 13f filing list,
warren buffett 13f,
baker brothers 13f,
fundsmith 13f ,
valueact 13f,
greenlight capital 13f,
dorsey asset management 13f,
ra capital 13f,
dragoneer 13f,
vanguard group inc 13f,
hillhouse 13f,
citadel 13f,
morgan stanley 13f,
spruce house 13f,
fmr llc 13f,
sachem head 13f,
duquesne capital 13f,
maverick capital 13f,
soros fund management 13f,
light street capital 13f,
bronte capital 13f,
corvex 13f,
adw capital 13f,
arlington value capital 13f,
greenhaven road capital 13f,
fisher investments 13f,
bares capital management 13f,
generation investment management 13f,
giverny capital 13f,
goldman sachs 13f,
omega advisors 13f,
thomson reuters 13f